Gemcitabine-Cisplatin Chemotherapy Before Lung Resection: A Case-Matched Analysis of Early Outcome

Annals of Thoracic Surgery

Volumn 81, Issue 6, 2006, Pages 1963-1968

  Brunelli, Alessandro ^a   Xiume', Francesco ^a   Al Refai, Majed ^a   Salati, Michele ^a   Marasco, Rita ^a   Sabbatini, Armando ^a  

^a Azienda Ospedaliera Umberto I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ATELECTASIS; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PNEUMONIA; PREOPERATIVE CARE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SCORING SYSTEM; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD TRANSFUSION; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DRUG EVALUATION; FEMALE; HUMANS; INTENSIVE CARE; LENGTH OF STAY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SELECTION BIAS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33747130429     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.01.012     Document Type: Article

References (31)

1. Pass H.I., Pogrebniak H.W., Steinberg S.M., Mulshine J., and Minna J. Randomized trial of neoadjuvant therapy for lung cancer. interim analysis. Ann Thorac Surg 53 (1992) 992-998
2. Rosell R., Gomez-Codina J., Camps C., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330 (1994) 153-158
3. Roth J.A., Fossella F., Komaki R., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86 (1994) 673-680
4. Depierre A., Milleron B., Moro-Sibilot D., et al., French Thoracic Cooperative Group. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20 (2000) 247-253
5. Pisters K.M., Ginsberg R.J., Giroux D.J., et al., Bimodality Lung Oncology Team. Induction chemotherapy before surgery for early-stage lung cancer. a novel approach. J Thorac Cardiovasc Surg 119 (2000) 429-439
6. Cappuzzo F., Selvaggi G., Gregorc V., et al. Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable stage IIIA-bulky N2 and stage IIIB non small cell lung carcinoma. an Italian Lung Cancer Project Observational Study. Cancer 98 (2003) 128-134
7. Van Kooten M., Rosenberg M., Orlando M., et al. Neoadjuvant chemotherapy with gemcitabine and cisplatin in stage IIIA/IIIB non-small cell lung cancer. Invest New Drugs 20 (2002) 439-446
8. Depierre A., Westeel A., and Jacoulet P. Gemcitabine induction chemotherapy in non-small cell lung cancer. Semin Oncol 29 (2002) 55-60
9. Yang C.H., Tsai C.M., Wang L.S., et al. Gemcitabine and cisplatin in a multimodality treatment for locally advanced non small cell lung cancer. Br J Cancer 86 (2002) 190-195
10. Rinaldi M., and Crino L. Induction chemotherapy with gemcitabine and cisplatin in stage III non small cell lung cancer. Lung Cancer 34 Suppl 4 (2001) 25-30
11. Martin J., Ginsberg R.J., Abolhoda A., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer. the risks of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
12. Roberts J.R., Eustis C., Devore R., Carbone D., Choy H., and Johnson D. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg 72 (2001) 885-888
13. Perrot E., Guibert B., Mulsant P., et al. Preoperative chemotherapy does not increase complications after non-small cell lung cancer resection. Ann Thorac Surg 80 (2005) 423-427
14. Novoa N., Varela G., and Jimenez M.F. Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy. Eur J Cardiothorac Surg 20 (2001) 700-704
15. Doddoli C., Thomas P., Thirion X., Seree Y., Giudicelli R., and Fuentes P. Postoperative complications in relation with induction therapy for lung cancer. Eur J Cardiothorac Surg 20 (2001) 385-390
16. Siegenthaler M.P., Pisters K.M., Merriman K.W., et al. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg 71 (2001) 1105-1112
17. Brunelli A., Al Refai M., Monteverde M., Borri A., Salati M., and Fianchini A. Stair climbing test predicts cardiopulmonary complications after lung resection. Chest 121 (2002) 1106-1110
18. Rosenbaum P.R., and Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
19. Blackstone E.H. Comparing apples and oranges. J Thorac Cardiovasc Surg 123 (2002) 8-15
20. Breiman L. Bagging predictors. Machine Learn 24 (1996) 123-140
21. Birim O., Maat A.P.W.M., Kappetein A.P., van Meerbeeck J.P., Damhuis R.A.M., and Bogers A.J.J.C. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardiothorac Surg 23 (2003) 30-34
22. Rosenbaum P.R., and Rubin D.B. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79 (1984) 516-524
23. Rosenbaum P.R. Optimal matching for observational studies. J Am Stat Assoc 84 (1989) 1024-1032
24. Spira A., and Ettinger D.S. Multidisciplinary management of lung cancer. N Engl J Med 350 (2004) 379-392
25. Koch C.G., Khandwala F., Nussmeier N., and Blackstone E.H. Gender and outcomes after coronary artery bypass grafting. a propensity-matched comparison. J Thorac Cardiovasc Surg 126 (2003) 2032-2043
26. Leo F., Solli P., Spaggiari L., et al. Respiratory function changes after chemotherapy. an additional risk for postoperative respiratory complications?. Ann Thorac Surg 77 (2004) 260-265
27. Maas K.W., van der Lee I., Bolt K., Zanen P., Lammers J.W., and Schramel F.M. Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment. Lung Cancer 41 (2003) 345-351
28. Markos J., Mullan B.P., Hillman D.R., et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 139 (1989) 902-910
29. Olsen G.N., Bolton J.W.R., Weiman D.S., and Hornung C.A. Stair climbing as an exercise test to predict the postoperative complications of lung resection. two years experience. Chest 99 (1991) 587-590
30. Harpole D.H., DeCamp M.M., Daley J., et al. Prognostic models of thirty day mortality and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg 117 (1999) 969-979
31. Berrisford R., Brunelli A., Rocco G., Treasure T., Utley M., and Audit and Guidelines Committee of the European Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgery. The European Thoracic Surgery database project. modeling the risk of in-hospital death following lung resection. Eur J Cardiothorac Surg 28 (2005) 306-311